Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

about

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

Item

http://www.wikidata.org/entity/Q36275331

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@ast

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@en

type

Item

label

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@ast

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@en

prefLabel

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@ast

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@en

P1476

Treating non-ST-segment elevation ACS. Pros and cons of current strategies.

@en

P2093

Enrique V Carbajal

http://www.w3.org/2001/XMLSchema#string

Prakash Deedwania

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Inflammation, atherosclerosis, and coronary artery disease

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

P304

23-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2005.09.1704

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16201305

http://www.w3.org/2001/XMLSchema#string